Literature DB >> 10482318

Treatment of Wilson's disease with zinc.

G J Brewer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10482318     DOI： 10.1016/s0022-2143(99)90213-5

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  5 in total

Review 1.  Clinical management of Wilson disease.

Authors:  Peter Hedera
Journal:  Ann Transl Med       Date:  2019-04

2.  Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.

Authors:  Clavia Ruth Wooton-Kee; Ajay K Jain; Martin Wagner; Michael A Grusak; Milton J Finegold; Svetlana Lutsenko; David D Moore
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

Review 3.  Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature.

Authors:  Rachel M Taylor; Yuan Chen; Anil Dhawan
Journal:  Eur J Pediatr       Date:  2008-12-09       Impact factor: 3.183

4.  Extracellular zinc and ATP-gated P2X receptor calcium entry channels: New zinc receptors as physiological sensors and therapeutic targets.

Authors:  Erik M Schwiebert; Lihua Liang; Nai-Lin Cheng; Clintoria Richards Williams; Dragos Olteanu; Elisabeth A Welty; Akos Zsembery
Journal:  Purinergic Signal       Date:  2005-12-03       Impact factor: 3.765

5.  Presentation, diagnosis and outcome of predominantly hepatic Wilson's disease in adult Saudi patients: a single centre experience.

Authors:  Ibrahim Altraif; Fayaz A Handoo; Hamdan Al Ghamdi; Abdulrahman Aljumah; Mohammed Al Jumah; Mohammed Afzal
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.